Tiziana Life Sciences Ltd (TLSA)

Tiziana Life Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	1.18	18.12	42.19	65.82	0.2
Cash & Cash Equivalents	1.18	18.12	42.19	65.82	0.2
Cash Growth	-93.47%	-57.04%	-35.91%	32812.00%	-96.23%
Receivables	2.36	1.91	1.76	1.31	0.78
Other Current Assets	3.79	4.25	4.74	3.05	0.53
Total Current Assets	7.34	24.28	48.68	70.18	1.51
Property, Plant & Equipment	0.29	0.39	0.02	0.36	0.44
Long-Term Investments	4.55	1.81	0	0	0
Goodwill and Intangibles	0	0	0.13	0.12	0
Other Long-Term Assets	0	0	0	0	0.43
Total Long-Term Assets	4.85	2.2	0.15	0.48	0.87
Total Assets	12.18	26.48	48.83	70.66	2.38
Accounts Payable	6.39	6.53	7.54	7.31	6.99
Current Debt	0.14	0.12	0	0.59	0.28
Other Current Liabilities	0.01	0.01	0.01	0.09	0.08
Total Current Liabilities	6.54	6.66	7.55	7.98	7.35
Long-Term Debt	0.11	0.24	0	0.29	0.54
Total Long-Term Liabilities	0.11	0.24	0	0.29	0.54
Total Liabilities	6.65	6.91	7.55	8.27	7.89
Total Debt	0.25	0.37	0	0.88	0.82
Debt Growth	-32.33%	-	-	7.20%	-
Retained Earnings	-133.68	-116.26	-108.06	-84.65	-60.04
Comprehensive Income	-1.64	-3.13	0.45	5.41	1.94
Shareholders' Equity	5.54	19.57	41.28	62.39	-5.51
Net Cash / Debt	0.94	17.76	42.19	64.95	-0.62
Net Cash / Debt Growth	-94.73%	-57.91%	-35.04%	-	-
Working Capital	0.8	17.62	41.13	62.2	-5.85
Book Value Per Share	0.05	0.19	0.42	0.91	-0.08

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).